Costimulatory Pathways: Physiology and Potential Therapeutic Manipulation in Systemic Lupus Erythematosus
System lupus erythematosus (SLE) is an immune-complex-mediated autoimmune condition with protean immunological and clinical manifestation. While SLE has classically been advocated as a B-cell or T-cell disease, it is unlikely that a particular cell type is more pathologically predominant than the ot...
Saved in:
Main Authors: | Nien Yee Kow, Anselm Mak |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2013/245928 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Pathology of T Cells in Systemic Lupus Erythematosus
by: Anselm Mak, et al.
Published: (2014-01-01) -
Endoplasmic Reticulum Stress in Systemic Lupus Erythematosus and Lupus Nephritis: Potential Therapeutic Target
by: Hui-Yuan Li, et al.
Published: (2023-01-01) -
Systemic Lupus Erythematosus
by: Chaim Putterman, et al.
Published: (2012-01-01) -
Programmed Cell Death Pathways in the Pathogenesis of Systemic Lupus Erythematosus
by: Fangyuan Yang, et al.
Published: (2019-01-01) -
SIRI and SII as potential biomarkers of disease activity and lupus nephritis in systemic lupus erythematosus
by: Chi-Hui Yang, et al.
Published: (2025-01-01)